Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
American Journal of Hospital Pharmacy
|
December 1, 1978
Audit of the de Haen Drugs-In-Use Drug Information System
W R Grove, P P Lamy, C L Fortner
Clinical Pharmacy
|
July 1, 1982
Review of amsacrine, an investigational antineoplastic agent
W R Grove, C L Fortner, P H Wiernik
Drug Intelligence & Clinical Pharmacy
|
January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesis
C L Fortner, R S Finley, W R Grove
Drug Intelligence & Clinical Pharmacy
|
May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventions
R S Finley, C L Fortner, W R Grove
American Journal of Hospital Pharmacy
|
September 1, 1977
High-dose methotrexate with folinic acid rescue
J F Bender, W R Grove, C L Fortner
Investigational New Drugs
|
January 1, 1986
CI-921: an analog of amsacrine with experimental activity against solid tumors
W R Grove, L W DeLap, A J Grillo-López
American Journal of Hospital Pharmacy
|
June 1, 1975
Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug
C L Fortner, W R Grove, D Bowie, et al.
Blood
|
February 1, 1982
Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia
R J Esterhay, P H Wiernik, W R Grove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors
E C Dees, L R Whitfield, W R Grove, et al.
Clinical Pharmacy
|
March 1, 1985
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure
D S Roffman, M M Applefeld, W R Grove, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
American Journal of Hospital Pharmacy
|
December 1, 1978
Audit of the de Haen Drugs-In-Use Drug Information System
W R Grove, P P Lamy, C L Fortner
Clinical Pharmacy
|
July 1, 1982
Review of amsacrine, an investigational antineoplastic agent
W R Grove, C L Fortner, P H Wiernik
Drug Intelligence & Clinical Pharmacy
|
January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesis
C L Fortner, R S Finley, W R Grove
Drug Intelligence & Clinical Pharmacy
|
May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventions
R S Finley, C L Fortner, W R Grove
American Journal of Hospital Pharmacy
|
September 1, 1977
High-dose methotrexate with folinic acid rescue
J F Bender, W R Grove, C L Fortner
Investigational New Drugs
|
January 1, 1986
CI-921: an analog of amsacrine with experimental activity against solid tumors
W R Grove, L W DeLap, A J Grillo-López
American Journal of Hospital Pharmacy
|
June 1, 1975
Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug
C L Fortner, W R Grove, D Bowie, et al.
Blood
|
February 1, 1982
Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia
R J Esterhay, P H Wiernik, W R Grove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors
E C Dees, L R Whitfield, W R Grove, et al.
Clinical Pharmacy
|
March 1, 1985
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure
D S Roffman, M M Applefeld, W R Grove, et al.
Page
of 2